Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:antibiotic |
| gptkbp:activeIngredient |
gptkb:cefprozil
|
| gptkbp:approvalYear |
1992
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J01DB
|
| gptkbp:chemicalFormula |
C18H19N3O5S
|
| gptkbp:contraindication |
hypersensitivity to cephalosporins
|
| gptkbp:drugClass |
cephalosporin
|
| gptkbp:eliminationHalfLife |
1.3 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cefzil
|
| gptkbp:indication |
gptkb:sinusitis
bronchitis skin infections tonsillitis otitis media pharyngitis |
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea rash |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:Valeant_Pharmaceuticals_International
|
| gptkbp:bfsLayer |
7
|